Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.73 USD | -9.60% | -3.87% | -35.00% |
Mar. 29 | First Wave BioPharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 14 | Sector Update: Health Care Stocks Retreating Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.00% | 5.53M | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+47.70% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- FWBI Stock
- News First Wave BioPharma, Inc.
- First Wave to Initiate Phase 2 Trial to Test Enhanced Adrulipase Formulation to Treat Exocrine Pancreatic Insufficiency